Supernus, Inc.
INDV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001625297
In the last 90 days, Supernus, Inc. insiders filed 1 open-market purchase and 0 sales; 340 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.
Other share classesSUPN
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Supernus, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $53.5K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$53.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Supernus, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mottola Frank | SVP, Chief Tech. Ops. Officer | 30,099 | Nov 4, 2026 | 1 |
| Horich William Todd | SVP, Chief Commercial Officer | – | Nov 4, 2026 | 1 |
| Dec Timothy C | SVP, Chief Financial Officer | 14,059 | Nov 4, 2026 | 1 |
| Barlow Carrolee | Director | 41,652 | Nov 4, 2026 | 1 |
| Bhatt Padmanabh P. | SVP of IP, CSO | 28,702 | Nov 4, 2026 | 1 |
| Sensenig Bethany | Director | – | Nov 4, 2026 | 1 |
| Gemayel Georges | Director | 42,009 | Nov 4, 2026 | 1 |
| Khattar Jack A. | Chief Executive Officer | 1,475,569Indirect | Nov 4, 2026 | 1 |
| Rubin Jonathan | SVP, Chief Medical Officer | 21,529 | Nov 4, 2026 | 1 |
| Anderson Woodrow D | Chief Accounting Officer | 27,638 | Aug 27, 2026 | 4 |
| Heidbreder Christian | Chief Scientific Officer | 209,337 | Jul 13, 2026 | 4 |
| Ciaffoni Joseph | Chief Executive Officer | 790,330 | Jun 23, 2026 | 2 |
| Preblick Ryan | Chief Financial Officer | 284,751 | Jun 10, 2026 | 4 |
| Ninivaggi Daniel A | Director | 27,163 | May 14, 2026 | 3 |
| Kingsley Stuart A | Director | 12,100 | May 14, 2026 | 3 |
| Stejbach Mark | Director | 27,087 | May 14, 2026 | 3 |
| Thompson Juliet | Director | 12,973 | May 14, 2026 | 2 |
| Wheadon David E. | Director | 30,780 | May 14, 2026 | 3 |
| Ryan Barbara | Director | 12,242 | May 14, 2026 | 5 |
| Humphreys Keith | Director | 16,042 | May 14, 2026 | 3 |
| Burris Jeffrey W | Chief Legal Officer | 71,518 | Mar 5, 2026 | 2 |
| Barry Patrick A | Chief Commercial Officer | 31,380 | Feb 12, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)4:00 PM ET | Aug 27 | Same day | Anderson Woodrow DChief Accounting Officer | PPurchase | +1.50K | $35.69 | +$53.5K | +5.7%27.6K after | |
| Aug 5, 2026 (view filing)4:52 PM ET | Aug 5 | Same day | Anderson Woodrow DChief Accounting Officer | PPurchase | +1.50K | $36.28 | +$54.4K | +6.1%26.1K after | |
| Jul 13, 2026 (view filing)4:31 PM ET | Jul 10 | 3 days | Heidbreder ChristianChief Scientific Officer | SSale | −18.6K | $41.14 | −$764.6K | −8.2%209.3K after | 10b5-1 |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Heidbreder ChristianChief Scientific Officer | SSale | −18.6K | $38.06 | −$707.4K | −7.5%227.9K after | 10b5-1 |
| Jun 10, 2026 (view filing) | Jun 8 | 2 days | Preblick RyanChief Financial Officer | SSale | −36.0K | $37.70 | −$1.36M | −11.2%284.8K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 13 | Same day | Ryan BarbaraDirector | PPurchase | +8 | $31.09 | +$248.72 | +0.1%5.72K after | |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Ryan BarbaraDirector | PPurchase | +31 | $32.56 | +$1.01K | +0.5%5.72K after | |
| Mar 11, 2026 (view filing) | Mar 6 | 5 daysLate | Kingsley Stuart ADirector | PPurchase | +940 | $31.87 | +$30.0K | +20.2%5.58K after | |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Humphreys KeithDirector | PPurchase | +775 | $35.39 | +$27.4K | +15.4%5.80K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Ryan BarbaraDirector | PPurchase | +775 | $35.39 | +$27.4K | +65.2%1.96K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Wheadon David E.Director | PPurchase | +1.77K | $35.39 | +$62.7K | +14.0%14.4K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Stejbach MarkDirector | PPurchase | +775 | $35.39 | +$27.4K | +4.8%16.8K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Ninivaggi Daniel ADirector | PPurchase | +775 | $35.39 | +$27.4K | +4.8%16.9K after | 10b5-1 |